SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-105424
Filing Date
2006-05-09
Accepted
2006-05-09 16:14:18
Documents
5
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 184173
2 NON-QUALIFIED STOCK OPTION AGREEMENT dex1093.htm EX-10.93 24263
3 CERTIFICATION BY CEO dex311.htm EX-31.1 8958
4 CERTIFICATION BY CFO dex312.htm EX-31.2 8906
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 5604
  Complete submission text file 0001193125-06-105424.txt   233292
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 06821184
SIC: 2834 Pharmaceutical Preparations